Rare diseases
Investigational molecules
Locations
Hollerithallee 20, Marienwerder, 30419 Hanover, Germany
Research activity is centered on acute myocardial infarction and subsequent left-sided heart failure, with attention to patients who develop reduced left ventricular ejection fraction after STEMI or NSTEMI.
The clinical focus reflects interest in conditions where myocardial damage leads to persistent ventricular dysfunction and symptomatic cardiac insufficiency.
Cardior Pharmaceuticals GmbH runs clinical trials in conditions such as Cardiac failure, Cardiac failure chronic, Cardiac failure acute, Left ventricular failure, among others.
Clinical trials registered by this sponsor – none is enrolling right now.
CzechiaIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
